SOLV Stock Overview
A healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Solventum Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$66.20 |
| 52 Week High | US$96.05 |
| 52 Week Low | US$47.16 |
| Beta | 0 |
| 11 Month Change | 9.26% |
| 3 Month Change | 17.09% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -17.25% |
Recent News & Updates
Recent updates
Solventum (NYSE:SOLV) Has A Pretty Healthy Balance Sheet
Aug 18
Solventum: Stumbling Out Of The Gate
Jul 07Solventum Corporation (NYSE:SOLV) Shares Could Be 27% Below Their Intrinsic Value Estimate
Jun 26Solventum: A Reasonable Start, Still Some Questions To Be Asked
May 173M Says Bye To Solventum - Why I Stick To My Bullish Call
Apr 02Shareholder Returns
| SOLV | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 3.3% | -1.4% | -4.4% |
| 1Y | n/a | 14.0% | 19.1% |
Return vs Industry: Insufficient data to determine how SOLV performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how SOLV performed against the US Market.
Price Volatility
| SOLV volatility | |
|---|---|
| SOLV Average Weekly Movement | 5.0% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: SOLV's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine SOLV's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2023 | 22,000 | Bryan Hanson | www.solventum.com |
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.
Solventum Corporation Fundamentals Summary
| SOLV fundamental statistics | |
|---|---|
| Market cap | US$11.43b |
| Earnings (TTM) | US$1.06b |
| Revenue (TTM) | US$8.21b |
10.8x
P/E Ratio1.4x
P/S RatioIs SOLV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SOLV income statement (TTM) | |
|---|---|
| Revenue | US$8.21b |
| Cost of Revenue | US$3.53b |
| Gross Profit | US$4.68b |
| Other Expenses | US$3.62b |
| Earnings | US$1.06b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.13 |
| Gross Margin | 56.98% |
| Net Profit Margin | 12.89% |
| Debt/Equity Ratio | 289.7% |
How did SOLV perform over the long term?
See historical performance and comparison